Varicella pneumonia in an agammaglobulinemic patient cured by cytosine-arabinoside
Bassetti, D.; Giacchino, R.; Dimic, E.
Panminerva Medica 16(5-6): 177-180
1974
ISSN/ISBN: 0031-0808 PMID: 4418304 Document Number: 78035
Document emailed within 1 workday
Related Documents
Goudsmit, R. 1972: Cytosine arabinoside in the treatment of severe herpes zoster and varicella Nederlands Tijdschrift Voor Geneeskunde 116(5): 200Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Kobayashi, S.; Sakai, H.; Tomiazwa, T.; Koiso, H.; Kim, K.; Ueki, K.; Tamura, J.; Yano, S.; Naruse, T.; Karasawa, M. 1999: Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis Journal of Medicine 30(1-2): 101-109
Nakamura, M.; Kanazawa, M.; Yamaguchi, K.; Akizuki, M.; Satoh, S.; Inada, S. 1996: Pneumonia caused by varicella-zoster virus in a patient with rheumatoid arthritis Nihon Kyobu Shikkan Gakkai Zasshi 34(5): 610-615
Peterlejtner, E. 1978: Ophthalmic zoster treated with cytosine arabinoside Klinika Oczna 48(2): 71-72
Kufe, D.W.; Spriggs, D.R. 1985: Biochemical and cellular pharmacology of cytosine arabinoside Seminars in Oncology 12(2 Suppl 3: 34-48
Hanka, L.J.; Kuentzel, S.L.; Neil, G.L. 1970: Improved microbiological assay for cytosine arabinoside (NSC-63878) Cancer ChemoTherapy Reports 54(6): 393-397
Derulska, D.; Rokicka-Milewska, R. 1975: Cytosine arabinoside in the treatment of acute leukemia in children Pediatria Polska 50(6): 723-728
Tatsumi, N.; Masaoka, T.; Ueda, Y.; Senda, N. 1970: Treatment of leukemia with cytosine arabinoside--on the intensification of remission Gan no Rinsho. Japan Journal of Cancer Clinics 16(7): 706-712
Gallo, J.H.; Rozenberg, M.C. 1986: Response of refractory anemia to low-dose cytosine arabinoside Australian and New Zealand Journal of Medicine 16(2): 231-233
Madon, E.; Baroncelli, P.G.; Sacerdote, A.; Roberi, P.L. 1971: Treatment of acute leukemias in the infancy with cytosine arabinoside Minerva Pediatrica 23(26): 1125-1129
Pytel-Dabrowska, T.; Balcar-Boroń, A.; Nowaczyk-Michalak, A. 1980: Cytosine arabinoside in the treatment of herpes simplex and chickenpox Wiadomosci Lekarskie 33(12): 957-959
Surkova, N.I.; Malashenko, A.M. 1975: Cytogenetic effect of mitomycin C and cytosine arabinoside on mice of different genotypes Genetika 11(9): 38-45
Hirschmann, W.D.; Kovacs, E.L.; Gerecke, D.; Kaulen, H.D.; Voigtmann, R.; Gross, R. 1975: Method of administration and inactivation of cytosine arabinoside in acute leukemia Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1114-1116
Morrison, P.F.; Lincoln, T.L.; Aroesty, J. 1975: Disposition of cytosine arabinoside (NSC-63878) and its metabolites: a pharmacokinetic simulation Cancer ChemoTherapy Reports 59(4): 861-876
Lin, S.F.; Liu, H.W.; Chen, T.P. 1990: Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C) Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 53(1): 45-50
Klener, P.; Háber, J. 1985: Treatment of refractory leukemia with high-dose cytosine arabinoside Neoplasma 32(1): 113-117
Yang, G.S.; Minden, M.D.; McCulloch, E.A. 1993: Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside Leukemia 7(7): 1012-1019
Wdzieczak-Bakala, J.; Guigon, M.; Lenfant, M.; Frindel, E. 1983: Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatment Biomedicine and PharmacoTherapy 37(9-10): 467-471
Kreis, W.; Woodcock, T.M.; Gordon, C.S.; Krakoff, I.H. 1977: Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man Cancer Treatment Reports 61(7): 1347-1353